Child and Adolescent Registry for Participants With Narcolepsy

Launched by JAZZ PHARMACEUTICALS · May 21, 2021

Keywords

ClinConnect Summary

The CATNAP trial is a study that aims to learn more about narcolepsy in children and teenagers. Narcolepsy is a condition that affects sleep, causing excessive daytime sleepiness and sudden sleep attacks. This registry will collect information to help researchers understand how narcolepsy affects young people over time. The study is open to any child or adolescent under 18 years old who has been diagnosed with narcolepsy by a doctor. Participants will need to be comfortable completing the necessary consent forms and participating in English.

If you or someone you know meets these criteria, you can expect to be part of a larger effort to gather important information about narcolepsy in young patients. The study is currently recruiting participants from 16 active clinical sites and also offers a virtual option, making it easier for people across the United States to join. For more details or to enroll, you can visit the CATNAP website or reach out via email. This is a great opportunity to contribute to research that may improve the understanding and treatment of narcolepsy in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any child or adolescent with a physician-confirmed diagnosis of narcolepsy
• • Age less than 18 years
• • Willing to participate in the Registry and complete the informed consent form
• • Able to participate in English based registry
• Exclusion Criteria:
• • Age 18 years or more
• • Fail to complete the informed consent form